Concord Drugs Ltd (CNCO)

Currency in INR
54.73
-1.11(-1.99%)
Closed·
CNCO Scorecard
Full Analysis
Trading at a high earnings multiple
CNCO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.7356.95
52 wk Range
26.1067.00
Key Statistics
Bid/Ask
54.74 / 54.73
Prev. Close
55.84
Open
56.95
Day's Range
54.73-56.95
52 wk Range
26.1-67
Volume
11.12K
Average Volume (3m)
35.63K
1-Year Change
47.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNCO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Concord Drugs Ltd Company Profile

Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products. The company also provides ready-to-fill pellets and multiple unit pellets system; drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. Concord Drugs Limited was incorporated in 1995 and is based in Hyderabad, India.

Employees
185
Market
India

Compare CNCO to Peers and Sector

Metrics to compare
CNCO
Peers
Sector
Relationship
P/E Ratio
166.1x6.3x−0.5x
PEG Ratio
−5.890.110.00
Price/Book
1.6x1.1x2.6x
Price / LTM Sales
1.2x0.9x3.3x
Upside (Analyst Target)
-0.0%43.4%
Fair Value Upside
Unlock8.6%7.1%Unlock

Earnings

Latest Release
May 23, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
103.97M / --
EPS Revisions
Last 90 days

CNCO Income Statement

People Also Watch

9,251.70
BNRS
-0.77%
272.75
GHTL
-1.46%
160.50
THEH
-2.13%

FAQ

What Stock Exchange Does Concord Drugs Ltd Trade On?

Concord Drugs Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Concord Drugs Ltd?

The stock symbol for Concord Drugs Ltd is "CNCO."

What Is the Concord Drugs Ltd Market Cap?

As of today, Concord Drugs Ltd market cap is 547.30M.

What Is Concord Drugs Ltd's Earnings Per Share (TTM)?

The Concord Drugs Ltd EPS (TTM) is 0.34.

From a Technical Analysis Perspective, Is CNCO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Concord Drugs Ltd Stock Split?

Concord Drugs Ltd has split 0 times.

How Many Employees Does Concord Drugs Ltd Have?

Concord Drugs Ltd has 185 employees.

What is the current trading status of Concord Drugs Ltd (CNCO)?

As of 08 Aug 2025, Concord Drugs Ltd (CNCO) is trading at a price of 54.73, with a previous close of 55.84. The stock has fluctuated within a day range of 54.73 to 56.95, while its 52-week range spans from 26.10 to 67.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.